ProfileGDS4177 / 206438_x_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 86% 84% 86% 86% 83% 84% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated337.8886
GSM603099KU-812 non-treated298.6484
GSM603098KCL-22 Imatinib-treated372.4786
GSM603097KCL-22 non-treated361.6186
GSM603102JURL-MK1 Imatinib-treated267.2783
GSM603101JURL-MK1 non-treated285.0484